Title: Methods of Treating Ocular Conditions
Patent Number: 7,700,575
Filed: Oct. 12, 2006
Lead Inventor: Andrew Huang, University of Minnesota
The invention, the patent's abstract states, "provides siRNA specific for myocilin and mutant myocilin, and methods of treating ocular conditions and/or diseases."
Title: Methods and Compositions Related to Gene Silencing
Patent Number: 7,700,758